Lise Barbin (Merlay), PhD has a strong background in biochemistry and regulatory strategy within the pharmaceutical industry. With experience in writing various regulatory documentation, submission via centralized procedures, and collaborating with a multidisciplinary team, Lise has expertise in oncology, immune-mediated diseases, and neurological disorders. With a PhD in Biochemistry and experience in post-doc research, Lise has a solid foundation in molecular biology, biochemistry, microbiology, and cell biology.
Previous companies
January 1, 2024 - present
July, 2022
January, 2020
June, 2018